Abstract
The most frequent adverse physical health effect among World Trade Center Health Program (WTCHP) members is chronic rhinosinusitis (CRS), with some evidence supporting its association with the exposures to dust, gases, and toxicants. We selected the International Consensus Statement on Allergy and Rhinology: Rhinosinusitis (ICARS-RS-2021) as a comprehensive evidence-based guide on best practices for CRS diagnosis and treatment for the WTCHP.
Acknowledgments
The authors acknowledge the comments from the clinicians of the WTC HP Clinical Centers. This review did not involve human subjects research and was thus deemed exempt from institutional review board review.
Disclosure statement
The authors have no other relevant financial conflict of interest.